Gregory D. Perry
2013 - Eleven Biotherapeutics
In 2013, Gregory D. Perry earned a total compensation of $905.5K as Chief Financial and Business Officer at Eleven Biotherapeutics.
Compensation breakdown
| Option Awards | $901,562 |
|---|---|
| Salary | $3,923 |
| Total | $905,485 |
Perry received $901.6K in option awards, accounting for 100% of the total pay in 2013.
Perry also received $3.9K in salary.
Rankings
In 2013, Gregory D. Perry's compensation ranked 7,081st out of 12,286 executives tracked by ExecPay. In other words, Perry earned more than 42.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,081 out of 12,286 | 42nd |
Division Manufacturing | 2,523 out of 4,612 | 45th |
Major group Chemicals And Allied Products | 775 out of 1,462 | 47th |
Industry group Drugs | 576 out of 1,156 | 50th |
Industry Pharmaceutical Preparations | 461 out of 890 | 48th |
Source: SEC filing on May 7, 2015.
Perry's colleagues
We found two more compensation records of executives who worked with Gregory D. Perry at Eleven Biotherapeutics in 2013.